Tuesday 16 01 2018
The BREATH (Border and Regions Airways Training Hub) project, which is a cross-border partnership between University of the West of Scotland, Queen’s University Belfast and the Dundalk Institute of Technology, has been shortlisted for a Northern Ireland Healthcare Award.
The 19th annual Northern Ireland Healthcare Awards take place at the Europa Hotel, Belfast on Thursday 22 February 2018. The Awards are dedicated to celebrating those whose exceptional expertise and contribution to their profession have transformed the provision of healthcare for the better.
The BREATH project will develop cross-border research to better understand and alleviate the impact of Chronic Obstructive Pulmonary Disease (COPD).
COPD is an incurable lung disease that is a leading cause of death worldwide, and is particularly prevalent in both South West Scotland and Ireland. In Ayrshire & Arran and Dumfries & Galloway, COPD-related hospital admission is amongst the highest in the UK. It significantly impairs quality of life and has a high cost to health services and the wider economy.
The €7.7 million EU INTERREG VA funded BREATH project has established a world-class cluster of researchers who will help address the causes, treatment and potential prevention of COPD. In 2011 the annual economic burden of COPD across the EU was estimated at approximately €141.4 billion.
Throughout the five year project, over 30 researchers and doctoral students will work together not only to better understand COPD but to raise awareness of the disease to help encourage preventative measures and timely treatment and disease management.
We are delighted that the important work of the BREATH project has been recognised in this way and is shortlisted for a Northern Ireland Healthcare Award.Professor John Lockhart, Director of the UWS Institute of Biomedical and Environmental Health Research (IBEHR)
Professor John Lockhart, Director of the UWS Institute of Biomedical and Environmental Health Research (IBEHR), said: “Together with our Irish partners, BREATH offers a wonderful opportunity to gain new insights into lung disease. By better understanding this often ‘invisible’ killer disease, we hope to develop new and improved treatments – as well as helping prevent COPD by public awareness in the affected regions.”
Dr Gary Litherland, UWS Scientific Lead on BREATH added: “Deaths from respiratory diseases recently exceeded those from coronary heart disease in Scotland for the first time. Increasingly it is recognised that lung health needs to be made a national priority, as poor public awareness has resulted in an under-prioritisation of this disease.”